Franklin Resources’s Beam Therapeutics BEAM Stock Holding History
Bought
Maintained
Sold
Other funds holding BEAM
FCM
AIM
AVM
NAMA
Franklin Resources's BEAM Position: Q2 2026 in Review
Franklin Resources increased its Beam Therapeutics (BEAM) stake by 29% in Q2 2026, buying an estimated $209K and bringing the position to 30,407 shares worth $1.04M. The position accounts for ﹤0.01% of the portfolio, ranked #2259.
Franklin Resources first reported a position in BEAM in Q1 2020 and has held it in 14 quarters since. The position peaked at $5.41M in Q1 2020. 277 funds tracked by Wall St. Rank hold BEAM as of Q2 2026.
- Franklin Resources held 30,407 shares of Beam Therapeutics worth $1.04M as of Q2 2026.
- Franklin Resources bought 6,920 Beam Therapeutics shares in Q2 2026, an estimated $209K.
- Beam Therapeutics made up ﹤0.01% of Franklin Resources's portfolio in Q2 2026, its #2259 holding.
- Franklin Resources first reported a position in Beam Therapeutics in Q1 2020 and has held it in 14 quarters since.
- Franklin Resources's Beam Therapeutics position peaked at $5.41M in Q1 2020.
- 277 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2026.
Based on Franklin Resources's 13F filing for Q2 2026, filed 13 Aug 2026.